Head JLABS @ Shanghai
Sharon is a passionate and respected global health leader with extensive experience in business and product development across pharmaceuticals, medical devices, vaccines and technology platforms.
As Head of JLABS @ Shanghai, Sharon is responsible for setting the strategic direction and overseeing all operational activities for JLABS @ Shanghai, the first Johnson & Johnson Innovation – JLABS in Asia Pacific and the largest in its global network. Her responsibilities include managing the portfolio of JLABS in the region and collaborating with its internal and external business partners across multiple sectors to implement educational programming and drive high-quality company sourcing from innovation hotspots across Asia Pacific. In 2020, Sharon was recognized by Forbes China as one of the 50 Top Women in Tech.
Prior to joining Johnson & Johnson, Sharon was Head of Asia at Aeras, where she established its Beijing office for the Bill & Melinda Gates Foundation and focused on tuberculosis (TB) vaccines. She had previously served as a member of the Senior Leadership team for Baxter in Shanghai with responsibility for providing strategic direction and making deals to add to Baxter’s top line growth. She began her career working in Business Development for Sosei Heptares, a Japanese start-up turned international biopharma focused on CNS, immuno-oncology, gastroenterology, inflammation and other rare/specialty indications, based in London.
Sharon also holds prominent leadership appointments as a board member of Right 2 Thrive, focused on breaking the cycle of poverty in Kenya, and as a committee member of the China-Oxford Scholarship Fund in Shanghai and Beijing. She also teaches “Introduction to Vaccines: History, Development and Impact” at the Hong Kong Polytechnic University in the Dept. of Applied Biology and Chemical Technology.
Sharon received a Master Degree in Public Health (MPH) at Johns Hopkins Bloomberg School of Public Health, Baltimore, USA; a Master Degree in Business Administration (EMBA) at IE Business School, Madrid, Spain; a Doctorate Degree in Biochemistry and Cardiovascular Medicine (DPhil) at University of Oxford, UK; and a Master Degree in Molecular Biology and Cellular Biochemistry (MBioChem) at University of Oxford, UK.